| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 07/04/2001 | EP1112284A1 Piperazine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p53 |
| 07/04/2001 | EP1112252A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 07/04/2001 | EP1112250A1 Therapeutic compounds and methods |
| 07/04/2001 | CN1302287A Bioreductive cytotoxic agents |
| 07/04/2001 | CN1301697A Process for preparing 3,3-diaryl acrylyl morpholine |
| 07/03/2001 | US6255487 Process of preparing [2-(1-piperazinyl)ethoxy]methyl compounds |
| 07/03/2001 | US6254849 Zeolites with silicon, germanium oxide with aluminum gallium iron oxide and roasting |
| 07/03/2001 | CA2101310C Novel arylglycinamide derivatives and preparative processes therefor |
| 06/28/2001 | WO2001046200A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | WO2001046168A1 Tryptase inhibitors |
| 06/28/2001 | WO2001046167A1 α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS |
| 06/28/2001 | WO2001046166A2 Partially saturated calcium channel blockers |
| 06/28/2001 | WO2001046146A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046145A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046144A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046124A1 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |
| 06/28/2001 | WO2001045739A1 Remedies and/or preventives for nervous system disorders |
| 06/28/2001 | WO2001045709A1 Substituted piperazine and piperidine calcium channel blockers |
| 06/28/2001 | WO2001045694A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001010834A3 Antibacterial agents |
| 06/28/2001 | WO2001002380A8 Antipsychotic cyclic n-aralkyl amines |
| 06/28/2001 | DE19964224A1 New calcium complex of oxa-diaza-phosphaundecane derivative MS-325, useful as stabilizer for diagnostic compositions containing gadolinium complex of MS-325 and as antidote for heavy metal poisoning |
| 06/28/2001 | CA2394633A1 Therapeutic and/or prophylactic agent for nervous system disorder |
| 06/28/2001 | CA2394603A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | CA2394095A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | CA2392121A1 Tryptase inhibitors |
| 06/27/2001 | EP1110958A1 Alpha-arylethylpiperazine derivatives as neurokinin antagonists |
| 06/27/2001 | EP1110945A2 Azocompounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 06/27/2001 | EP1109805A1 Inhibitors of bacterial nad synthetase |
| 06/27/2001 | EP1109787A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 06/27/2001 | EP1109557A2 A method for preventing the onset of asthma |
| 06/27/2001 | EP1109542A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
| 06/27/2001 | CN1301259A & alpha; -(1-piperazinyl) ocetamido arenecarboxylic acid derivatives as antidiabetic agents |
| 06/27/2001 | CN1301161A Serotonergic 5HT receptor compounds for treating ocular and CNS disorders |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/26/2001 | US6252079 Intermediates in the synthesis of camptothecin and related compounds and synthesis thereof |
| 06/26/2001 | US6251949 Oxime derivatives, hydrazone derivatives and use thereof |
| 06/26/2001 | US6251944 (vitronectin receptor) integrin antagonist, useful for treating angiogenesis, tumor growth, tumor metastasis, osteoporosis and humoral hypercalcemia of malignancy |
| 06/26/2001 | US6251931 Oleamide agonists and as inhibitor of fatty acid amide hydrolase for inhibition of gap junction-mediated chemical and electrical transmission in glial cells of the animal |
| 06/26/2001 | US6251921 Administering thrombin inhibiting diamine compound to mammal |
| 06/26/2001 | US6251918 For therapy of stroke, cerebral ischemia, head trauma, or epilepsy |
| 06/26/2001 | US6251909 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 06/26/2001 | US6251833 Pesticide; herbicide |
| 06/26/2001 | US6251827 Acylsulfamoylbenzamides, crop protection compositions comprising them, and processes for their preparation |
| 06/21/2001 | WO2001044226A1 Serine protease inhibitors |
| 06/21/2001 | WO2001044223A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | WO2001044218A1 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals |
| 06/21/2001 | WO2001044192A1 Cyclic quaternary ammonium compounds |
| 06/21/2001 | WO2001044190A1 Anthracene derivatives as anti-cancer agents |
| 06/21/2001 | WO2001044189A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 06/21/2001 | WO2001044188A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 06/21/2001 | WO2001044161A2 Method for producing combinatorial libraries of aryl-substituted amines |
| 06/21/2001 | WO2001044160A2 Method for producing combinatorial amine libraries |
| 06/21/2001 | WO2001017955A3 Hydroxyacetamidobenzenesulphonamide derivatives |
| 06/21/2001 | US20010004669 For treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain and chronic paroxysmal hemicrania and headache associated with vascular disorders |
| 06/21/2001 | DE19961372A1 Verfahren zur Herstellung kombinatorischer Bibliotheken arylsubstituierter Amine Process for the preparation of combinatorial libraries of aryl-substituted amines |
| 06/21/2001 | DE19960377A1 Verfahren zur Herstellung kombinatorischer Aminbibliotheken Process for the preparation of combinatorial libraries amine |
| 06/21/2001 | DE10061948A1 Lichtempfindliche Harzzusammensetzung A photosensitive resin composition |
| 06/21/2001 | CA2395170A1 Anti-cancer agents (iii) |
| 06/21/2001 | CA2393711A1 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals |
| 06/21/2001 | CA2393706A1 Cyclic quaternary ammonium compounds |
| 06/21/2001 | CA2393027A1 Inhibitors of interleukin 5 gene expression |
| 06/20/2001 | EP1109059A2 Oxonol infrared radiation sensitive compounds |
| 06/20/2001 | EP1108715A1 Process for dehydration and purification of crude pyrrolidine |
| 06/20/2001 | EP1107953A1 Hydroxamic acid derivatives as proteinase inhibitors |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP1107745A1 Use of 5ht-6 antagonists |
| 06/20/2001 | CN1300288A Water soluble azoles as broad-spectrum antifungals |
| 06/20/2001 | CN1300287A Water soluble azoles as broad-spectrum antifungals |
| 06/20/2001 | CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 06/20/2001 | CN1300210A Hydroxamic acid derivatives as antibacterials |
| 06/20/2001 | CN1299813A N-substituted benzyl or phenyl aromatic amide compound and its use |
| 06/20/2001 | CN1067391C Piperidyl methyl oxazolidinone |
| 06/19/2001 | US6248748 Crop protection products |
| 06/19/2001 | US6248694 Mepiquat monoborate salt and thickening agent as plant growth regulators |
| 06/15/2001 | CA2328342A1 Photosensitive resin composition |
| 06/14/2001 | WO2001042249A1 Olefin polymerization cocatalysts derived from group-15 compounds and processes using them |
| 06/14/2001 | WO2001042204A1 N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof |
| 06/14/2001 | WO2001042201A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect |
| 06/14/2001 | WO2001042192A2 Vla-4 integrin antagonists |
| 06/14/2001 | US20010003749 Arylpiperazines having activity at the serotonin 1A receptor |
| 06/14/2001 | US20010003741 Aminoalcohol derivative and medicament comprising the same |
| 06/14/2001 | CA2391855A1 Olefin polymerization cocatalysts derived from group-15 compounds and processes using them |
| 06/14/2001 | CA2388686A1 Vla-4 integrin antagonists |
| 06/13/2001 | EP1106609A2 Aminoalcohol derivative and medicament comprising the same |
| 06/13/2001 | EP1106179A2 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/13/2001 | EP1105372A1 Methoximinophenylacetic acid amides |
| 06/13/2001 | EP1105368A1 Photoactivatable bases containing nitrogen |
| 06/13/2001 | EP1105366A1 Divinylstilbenesulfonic acid derivatives |
| 06/13/2001 | EP0927029A4 Novel methods |
| 06/13/2001 | EP0863132B1 Ketonitrile derivatives and antibacterial agent and drug containing the same |
| 06/13/2001 | DE19956414A1 Verfahren zur Herstellung von chiralen Aminen durch homogen katalysierte asymmetrische Hydrierung von Enaminen A process for the preparation of chiral amines by homogeneously catalyzed asymmetric hydrogenation of enamines |
| 06/13/2001 | CN1299344A Novel urea derivatives |
| 06/13/2001 | CN1067065C (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate |
| 06/12/2001 | US6245952 Reacting carbonyl substrate with silane compound to reduce substrate in presence of catalytic amounts of active zinc compound, hydrolyzing obtained siloxane with basic agent to form alcohol, separating and purifying alcohol |
| 06/12/2001 | US6245767 Cardiovascualr disorders |
| 06/12/2001 | US6245449 Material for organoelectroluminescence device and use thereof |
| 06/12/2001 | CA2003388C Neuroprotective pharmaceutical compositions containing arylcyclohexylamines |
| 06/07/2001 | WO2001040219A2 Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination |